Cargando…

Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington’s Disease

Huntington’s disease (HD) is a neurodegenerative disorder characterized by deficits in movement control that are widely viewed as stemming from pathophysiological changes in the striatum. Giant, aspiny cholinergic interneurons (ChIs) are key elements in the striatal circuitry controlling movement, b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tanimura, Asami, Lim, Sean Austin O., Aceves Buendia, Jose de Jesus, Goldberg, Joshua A., Surmeier, D. James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5159611/ https://www.ncbi.nlm.nih.gov/pubmed/28018188 http://dx.doi.org/10.3389/fnsys.2016.00102

Ejemplares similares

Enhanced GABAergic Inhibition of Cholinergic Interneurons in the zQ175(+/−) Mouse Model of Huntington's Disease
por: Lim, Sean Austin O., et al.
Publicado: (2021)

Corticostriatal synaptic adaptations in Huntington’s disease
por: Plotkin, Joshua L., et al.
Publicado: (2015)

Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion
por: Aceves Buendia, Jose de Jesus, et al.
Publicado: (2017)

Synaptic pathology in Huntington’s disease: Beyond the corticostriatal pathway
por: Barry, Joshua, et al.
Publicado: (2022)

Non-uniform distribution of dendritic nonlinearities differentially engages thalamostriatal and corticostriatal inputs onto cholinergic interneurons
por: Oz, Osnat, et al.
Publicado: (2022)

Activity Patterns in the Neuropil of Striatal Cholinergic Interneurons in Freely Moving Mice Represent Their Collective Spiking Dynamics
por: Rehani, Rotem, et al.
Publicado: (2019)

Disposition of Proteins and Lipids in Synaptic Membrane Compartments Is Altered in Q175/Q7 Huntington’s Disease Mouse Striatum
por: Iuliano, Maria, et al.
Publicado: (2021)

The Onset and Progression of Hippocampal Synaptic Plasticity Deficits in the Q175FDN Mouse Model of Huntington Disease
por: Quirion, Jade G., et al.
Publicado: (2019)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

Astrocytic engagement of the corticostriatal synaptic cleft is disrupted in a mouse model of Huntington’s disease
por: Villanueva, Carlos Benitez, et al.
Publicado: (2023)

Neurocardiovascular deficits in the Q175 mouse model of Huntington's disease
por: Cutler, Tamara S., et al.
Publicado: (2017)

Synaptic determinants of cholinergic interneurons hyperactivity during parkinsonism
por: Padilla-Orozco, Montserrat, et al.
Publicado: (2022)

Global Rhes knockout in the Q175 Huntington’s disease mouse model
por: Heikkinen, Taneli, et al.
Publicado: (2021)

Striatal cholinergic interneuron regulation and circuit effects
por: Lim, Sean Austin O., et al.
Publicado: (2014)

Thalamostriatal degeneration contributes to dystonia and cholinergic interneuron dysfunction in a mouse model of Huntington’s disease
por: Crevier-Sorbo, Gabriel, et al.
Publicado: (2020)

Progression of basal ganglia pathology in heterozygous Q175 knock‐in Huntington's disease mice
por: Deng, Yunping, et al.
Publicado: (2020)

Rescuing the Corticostriatal Synaptic Disconnection in the R6/2 Mouse Model of Huntington’s Disease: Exercise, Adenosine Receptors and Ampakines
por: Cepeda, Carlos, et al.
Publicado: (2010)

Abnormal Brain Development in Huntington’ Disease Is Recapitulated in the zQ175 Knock-In Mouse Model
por: Zhang, Chuangchuang, et al.
Publicado: (2020)

Synaptic mechanisms underlying modulation of locomotor-related motoneuron output by premotor cholinergic interneurons
por: Nascimento, Filipe, et al.
Publicado: (2020)

Dysregulation of Corticostriatal Connectivity in Huntington’s Disease: A Role for Dopamine Modulation
por: Rangel-Barajas, Claudia, et al.
Publicado: (2016)

Metformin treatment reduces motor and neuropsychiatric phenotypes in the zQ175 mouse model of Huntington disease
por: Sanchis, Ana, et al.
Publicado: (2019)

The Urine Metabolome of R6/2 and zQ175DN Huntington’s Disease Mouse Models
por: Speziale, Roberto, et al.
Publicado: (2023)

Comprehensive Behavioral and Molecular Characterization of a New Knock-In Mouse Model of Huntington’s Disease: zQ175
por: Menalled, Liliana B., et al.
Publicado: (2012)

Impaired Performance of the Q175 Mouse Model of Huntington’s Disease in the Touch Screen Paired Associates Learning Task
por: Piiponniemi, Tuukka O., et al.
Publicado: (2018)

Exercise-Induced Fatigue Impairs Bidirectional Corticostriatal Synaptic Plasticity
por: Ma, Jing, et al.
Publicado: (2018)

Reinforcement determines the timing dependence of corticostriatal synaptic plasticity in vivo
por: Fisher, Simon D., et al.
Publicado: (2017)

Long-Term Shaping of Corticostriatal Synaptic Activity by Acute Fasting
por: Campanelli, Federica, et al.
Publicado: (2021)

Cholinergic deficits selectively boost cortical intratelencephalic control of striatum in male Huntington’s disease model mice
por: Pancani, Tristano, et al.
Publicado: (2023)

Prefrontal cortical ChAT-VIP interneurons provide local excitation by cholinergic synaptic transmission and control attention
por: Obermayer, Joshua, et al.
Publicado: (2019)

Microglia and complement mediate early corticostriatal synapse loss and cognitive dysfunction in Huntington’s disease
por: Wilton, Daniel K., et al.
Publicado: (2023)

Dual Nitrergic/Cholinergic Control of Short-Term Plasticity of Corticostriatal Inputs to Striatal Projection Neurons
por: Blomeley, Craig P., et al.
Publicado: (2015)

Studies on the Q175 Knock-in Model of Huntington’s Disease Using Functional Imaging in Awake Mice: Evidence of Olfactory Dysfunction
por: Ferris, Craig F., et al.
Publicado: (2014)

Time-Restricted Feeding Improves Circadian Dysfunction as well as Motor Symptoms in the Q175 Mouse Model of Huntington’s Disease
por: Wang, Huei-Bin, et al.
Publicado: (2018)

Cholinergic Interneurons Are Differentially Distributed in the Human Striatum
por: Bernácer, Javier, et al.
Publicado: (2007)

Dysfunctional Behavioral Modulation of Corticostriatal Communication in the R6/2 Mouse Model of Huntington’s Disease
por: Hong, S. Lee, et al.
Publicado: (2012)

Prelimbic cortical targets of ventromedial thalamic projections include inhibitory interneurons and corticostriatal pyramidal neurons in the rat
por: Sieveritz, Bianca, et al.
Publicado: (2020)

AMPK amplifies Huntington's disease
por: Short, Ben
Publicado: (2011)

The Q175 Mouse Model of Huntington’s Disease Shows Gene Dosage- and Age-Related Decline in Circadian Rhythms of Activity and Sleep
por: Loh, Dawn H., et al.
Publicado: (2013)

Characterization of Behavioral, Neuropathological, Brain Metabolic and Key Molecular Changes in zQ175 Knock-In Mouse Model of Huntington’s Disease
por: Peng, Qi, et al.
Publicado: (2016)

Possible use of a H3R antagonist for the management of nonmotor symptoms in the Q175 mouse model of Huntington's disease
por: Whittaker, Daniel S., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lh2doctvbm9rastjt4fjtbmjh1